Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

UVA Health receives federal grant to expand the program for battling burnout among healthcare providers

UVA Health has received $2.14 million in federal support to expand its nationally lauded program that is battling burnout among healthcare providers and helping them cope with the exhaustion caused by the COVID-19 pandemic.

3 Feb 2022

Relationship between SARS-CoV-2 neurotropism and Alzheimer's disease

In a new study, researchers evaluated the neurotropism of SARS-CoV-2 and its impact on COVID-19 patients with and without neurological disorders like Alzheimer's disease.

3 Feb 2022

Study reveals peripheral blood biomarkers able to predict COVID-19 clinical outcomes in ICU admission

A new study involved the development of an immunological biomarker screen that upon ICU admission can predict the length of ICU stay or death.

3 Feb 2022

The impact of the strict 112-day lockdown in Melbourne, Australia

Scientists recently evaluated the impact of 112-day strict lockdown implemented in Melbourne, Australia, to control the transmission of SARS-CoV-2.

3 Feb 2022

Exploring human milk oligosaccharides as a method of COVID-19 prevention

New research was conducted to ascertain whether antiviral and immunomodulatory activities of human milk oligosaccharides can be efficacious in the prevention and treatment against COVID-19.

3 Feb 2022

Study finds no strong evidence to suggest vaccination improves symptoms of post-acute COVID-19 syndrome

In this study, researchers found no evidence of a strong effect of SARS-CoV-2 vaccination on the symptoms associated with PACS over time.

3 Feb 2022

Researchers explore sex disparities in COVID-19 outcomes

A new article presented the first longitudinal study of COVID-19 sex disparities across the United States.

3 Feb 2022

Neutralizing antibodies against SARS-CoV-2 variants induced by homologous and heterologous COVID-19 booster vaccination

In this study, scientists focused on identifying tentative cut-offs for large-scale evaluations of immune protection against SARS-CoV-2 and its variants.

3 Feb 2022

Study finds pediatric acute upper airway infection cases have increased during the Omicron variant surge

Researchers conducted a retrospective cohort study to determine if pediatric acute upper airway infection was more common during the surge of the Omicron strain of SARS-CoV-2 in the US.

3 Feb 2022

Protocol for a systematic review to evaluate the role of viral cultures for assessing airborne transmission of SARS-CoV-2

Researchers presented the protocol for a systematic review assessing viral cultures for airborne transmission of SARS-CoV-2.

3 Feb 2022

Study describes the first three days of SARS-CoV-2 infection in an ALI model of proximal airway epithelium

Researchers evaluated the initial three days of SARS-CoV-2 infection via scRNAseq dataset in humanized in vitro model.

3 Feb 2022

Evaluating vaccine effectiveness and determining differences across demographic and clinical risk factors of COVID-19

Researchers assessed the effectiveness of COVID-19 vaccines against the manifestations of SARS-CoV-2 symptoms across different cohorts.

3 Feb 2022

A relative COVID-19 survival analysis

Researchers from the University of California Riverside, Texas A & M University, Washington University, and the Medical College of Georgia have been investigating the risks of death by age due to COVID-19 infection compared to deaths by other causes in Hubei province, China.

3 Feb 2022

Red foxes susceptible to SARS-CoV-2 infection

Working towards the aim to determine the SARS-CoV-2 susceptibility of common wildlife species, the researchers in the United States have found that red fox (Vulpes vulpes) can experimentally become infected with SARS-CoV-2 and can shed virus in its oral and nasal secretions.

3 Feb 2022

Study results strongly support COVID mRNA vaccine boosters for nursing home residents

Researchers evaluate the vaccine effectiveness of mRNA booster dose in nursing home residents who completed the primary series of mRNA vaccination.

2 Feb 2022

Nanoparticle vaccine effective against eight SARS-CoV-2 variants in non-human primates

Researchers demonstrate that SARS-CoV-2 RBD-based nanoparticle vaccine induces neutralizing antibodies against SARS-CoV-2 variants.

2 Feb 2022

Antigenic map of SARS-CoV-2 variants reveals amino acid substitutions that govern immune escape and immunodominance

Researchers use antigenic cartography to analyze cross-reactivity patterns of eight groups of human sera on a panel of SARS-CoV-2 variants.

2 Feb 2022

Analysis of SARS-CoV-2 Omicron variant-associated travel restrictions worldwide

Researchers evaluate the travel restrictions placed by nations worldwide following the emergence of the SARS-CoV-2 Omicron variant.

2 Feb 2022

Omicron variant's 'milder' outcomes may be due to more population immunity

The SARS-CoV-2 Omicron variant's "milder" outcomes are likely due to more population immunity compared to earlier waves of the pandemic rather than the virus's properties, according to a paper by William Hanage, associate professor of epidemiology and co-director of the Center for Communicable Disease Dynamics at Harvard T.H. Chan School of Public Health, and Roby Bhattacharyya, assistant professor at Massachusetts General Hospital and Harvard Medical School and associate member at the Broad Institute of MIT and Harvard.

2 Feb 2022

Booster dose of Covaxin vaccine candidate neutralizes Omicron and Delta variants

Researchers evaluate the neutralization potential of sera samples from subjects boosted with the Covaxin against the SARS-CoV-2 Omicron variant.

2 Feb 2022

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

UVA Health receives federal grant to expand the program for battling burnout among healthcare providers

Relationship between SARS-CoV-2 neurotropism and Alzheimer's disease

Study reveals peripheral blood biomarkers able to predict COVID-19 clinical outcomes in ICU admission

The impact of the strict 112-day lockdown in Melbourne, Australia

Exploring human milk oligosaccharides as a method of COVID-19 prevention

Study finds no strong evidence to suggest vaccination improves symptoms of post-acute COVID-19 syndrome

Researchers explore sex disparities in COVID-19 outcomes

Neutralizing antibodies against SARS-CoV-2 variants induced by homologous and heterologous COVID-19 booster vaccination

Study finds pediatric acute upper airway infection cases have increased during the Omicron variant surge

Protocol for a systematic review to evaluate the role of viral cultures for assessing airborne transmission of SARS-CoV-2

Study describes the first three days of SARS-CoV-2 infection in an ALI model of proximal airway epithelium

Evaluating vaccine effectiveness and determining differences across demographic and clinical risk factors of COVID-19

A relative COVID-19 survival analysis

Red foxes susceptible to SARS-CoV-2 infection

Study results strongly support COVID mRNA vaccine boosters for nursing home residents

Nanoparticle vaccine effective against eight SARS-CoV-2 variants in non-human primates

Antigenic map of SARS-CoV-2 variants reveals amino acid substitutions that govern immune escape and immunodominance

Analysis of SARS-CoV-2 Omicron variant-associated travel restrictions worldwide

Omicron variant's 'milder' outcomes may be due to more population immunity

Booster dose of Covaxin vaccine candidate neutralizes Omicron and Delta variants

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in